Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of DCB07010 Adjuvant with Influenza Vaccine
NCT03293732Phase 1Completed
- Sponsor
- Advagene Biopharma Co., Ltd.
- Start
- Nov 2012
- Primary completion
- Mar 2013
- Modality
- Vaccines & Immunotherapeutics, Targeted Liposomes, Stealth (PEGylated) Liposomes
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of AD07010 in influenza (5 arms), sponsored by Advagene Biopharma Co., Ltd. Primary endpoint: Geometric Mean Titers at Day 28. Started Nov 2012; status: completed.
02
Drugs
AD07010
03
Conditions
influenza
Beyond the preview
Go deeper on NCT03293732.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03293732.